JIR
SUPN icon

James Investment Research’s Supernus Pharmaceuticals SUPN Stock Holding History

James Investment Research’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.09M Buy
21,004
+29
+0.1% +$1.48K 0.12% 158
2025
Q4 		$1.04M Hold
20,975
– – 0.11% 156
2025
Q3 		$1M Buy
20,975
+3,332
+19% +$134K 0.11% 161
2025
Q2 		$556K Hold
17,643
– – 0.07% 205
2025
Q1 		$578K Hold
17,643
– – 0.07% 195
2024
Q4 		$638K Sell
17,643
-1
-0% -$35 0.08% 191
2024
Q3 		$550K Buy
17,644
+5,022
+40% +$157K 0.06% 207
2024
Q2 		$338K Buy
+12,622
New +$366K 0.04% 257

Other funds holding SUPN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return